A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Lung Cancer
Authors: Aminah Jatoi, Howard L. Ritter, Amylou Dueck, Phuong L. Nguyen, Daniel A. Nikcevich, Ronnie F. Luyun, Bassam I. Mattar, Charles L. Loprinzi
Institution: Mayo Clinic
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: Illinois Oncology Research Association Community Clinical Oncology Program, Sanford Community Cancer Consortium, Alliance NCORP Research Base, G3737421695, TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, North Central Cancer Treatment Group, Cedar Rapids Oncology Project, Carle Cancer Center Community Clinical Oncology Program, Missouri Valley Cancer Consortium CCOP, Mentoring and Research in Cancer Palliative Care, Community Clinical Oncology Program, Duluth Community Clinical Oncology Program, Metro-Minnesota Community Clinical Oncology Program, Iowa Oncology Research Association, G8740717309
OpenAlex ID: W2116819815
